Alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders.

Initial treatment is a single dose of 0.2 mg meloxicam/kg body weight on the first day.

Treatment is to be continued once daily by oral administration (at 24-hour intervals) at a maintenance dose of 0.1 mg meloxicam/kg body weight. Each chewable tablet contains either 1 mg or 2.5 mg meloxicam, which corresponds to the daily maintenance dose for a 10 kg body weight dog, or a 25 kg body weight dog respectively. Each chewable tablet can be halved for accurate dosing according to the individual body weight of the animal.

Rheumocam chewable tablets can be administered with or without food, are flavoured and are taken by most dogs voluntarily.

The use of Rheumocam oral suspension for dogs may be considered for an even more precise dosing.

For dogs weighing less than 4 kg the use of Rheumocam oral suspension for dogs is recommended. A clinical response is normally seen within 3 – 4 days.

Treatment should be discontinued after 10 days if no clinical improvement is apparent. Contra-indications, warnings, etc.

Do not use in pregnant or lactating animals.

Do not use in animals suffering from gastrointestinal disorders such as irritation and haemorrhage, impaired hepatic, cardiac or renal function and haemorrhagic disorders.

Do not use in dogs less than 6 weeks of age or less than 4 kg body weight.

Do not use in case of hypersensitivity to the active substance or to any of the excipients.

This item requires a prescription from your local veterinarian.